{"id": "1358889377720639490", "creation": 1612819449.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 2, "like_count": 2, "quote_count": 0}}, "text": "Up 190% in 2021, Is #Novavax Still a Buy? - Analyst Weighs In\n\nWith 86% demonstrated effectiveness against the mutant strains, $NVAX is likely to be granted emergency use authorization in the US, UK &amp; Canada this month\n\n$JNJ $MRNA #COVID19 #vaccine\n\nhttps://t.co/xuWdSjkUln", "first_save": 1634559108.199414, "hashtags": ["#NOVAVAX", "#COVID19", "#VACCINE"]}